CASP16 | Caspase 16, apoptosis-related cysteine peptidase (putative) | Enzymes
| | | | | Group enriched |
CASP5 | Caspase 5, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Group enriched |
CBLC | Cbl proto-oncogene C, E3 ubiquitin protein ligase | Cancer-related genes
| | | | | Tissue enhanced |
CCK | Cholecystokinin | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCKAR | Cholecystokinin A receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CCKBR | Cholecystokinin B receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CCL15 | Chemokine (C-C motif) ligand 15 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL24 | Chemokine (C-C motif) ligand 24 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCL25 | Chemokine (C-C motif) ligand 25 | Predicted secreted proteins
| | | | | Group enriched |
CCR9 | Chemokine (C-C motif) receptor 9 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CD70 | CD70 molecule | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CDH17 | Cadherin 17, LI cadherin (liver-intestine) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDHR2 | Cadherin-related family member 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDHR5 | Cadherin-related family member 5 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDX1 | Caudal type homeobox 1 | Transcription factors
| | | | | Group enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | | Group enriched |
CEA | Uncharacterized protein | Predicted secreted proteins
| | | | | Tissue enhanced |
CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CEACAM18 | Carcinoembryonic antigen-related cell adhesion molecule 18 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CEACAM7 | Carcinoembryonic antigen-related cell adhesion molecule 7 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CELF3 | CUGBP, Elav-like family member 3 | | | | | | Group enriched |
CFC1 | Cripto, FRL-1, cryptic family 1 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
CFC1B | Cripto, FRL-1, cryptic family 1B | Predicted secreted proteins
| | | | | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
CHIA | Chitinase, acidic | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CHP2 | Calcineurin-like EF-hand protein 2 | Cancer-related genes
| | | | | Group enriched |
CHST5 | Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CLCA1 | Chloride channel accessory 1 | Predicted secreted proteins
| | | | | Group enriched |
CLCA4 | Chloride channel accessory 4 | Predicted membrane proteins
| | | | | Group enriched |
CLDN15 | Claudin 15 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CLDN18 | Claudin 18 | Predicted membrane proteins
| | | | | Group enriched |
CLDN23 | Claudin 23 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLDN3 | Claudin 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4F | C-type lectin domain family 4, member F | Predicted membrane proteins
| | | | | Tissue enhanced |
CLIC6 | Chloride intracellular channel 6 | Transporters
| | | | | Tissue enhanced |
CLRN1 | Clarin 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CLRN3 | Clarin 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
COL2A1 | Collagen, type II, alpha 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
COLCA1 | Colorectal cancer associated 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
CPA6 | Carboxypeptidase A6 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
CPO | Carboxypeptidase O | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CPS1 | Carbamoyl-phosphate synthase 1, mitochondrial | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Group enriched |
CREB3L3 | CAMP responsive element binding protein 3-like 3 | Predicted membrane proteins Transcription factors
| | | | | Group enriched |
CRYBA2 | Crystallin, beta A2 | Disease related genes
| | | | | Tissue enhanced |
CTD-2545M3.6 | | | | | | | Tissue enhanced |
CTSE | Cathepsin E | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CUBN | Cubilin (intrinsic factor-cobalamin receptor) | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
CXCL17 | Chemokine (C-X-C motif) ligand 17 | Predicted secreted proteins
| | | | | Tissue enhanced |